Merck Announces $70 Billion Investment to Expand U.S. Manufacturing and R&D
I'm PortAI, I can summarize articles.
Merck & Co. Inc. plans to invest over $70 billion in U.S. capital and R&D, including $12 billion for capital expenditures. New facilities in Virginia, Kansas, and Delaware will create 1,200 full-time jobs and support 15,000 construction jobs. These investments aim to enhance domestic production, innovation, and access to affordable medicines. The original content was published by Merck via Business Wire on December 19, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments